Teva Pharmaceuticals Usa

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Topiramate 25 mg Tablets Under Fasting Conditions

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Topiramate Tablets
Drug: Topamax® Tablets

First Posted Date: 2009-05-20

Last Posted Date: 2024-08-19

Lead Sponsor: Teva Pharmaceuticals USA

Target Recruit Count: 30

Registration Number: NCT00905606

Locations: 🇨🇦
Anapharm Inc., Sainte-Foy, Quebec, Canada

Topiramate 25 mg Capsule Mixed With Applesauce Under Fasting Conditions

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Topiramate 25 mg Capsules
Drug: Topamax® 25 mg Capsules
Other: Applesauce

First Posted Date: 2009-05-20

Last Posted Date: 2024-08-20

Lead Sponsor: Teva Pharmaceuticals USA

Target Recruit Count: 24

Registration Number: NCT00905346

Locations: 🇨🇦
Anapharm Inc., Sainte-Foy, Quebec, Canada

Topiramate 25 mg Capsules Under Fed Conditions

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Topamax® Capsules, 25 mg
Drug: Topiramate Capsules, 25 mg

First Posted Date: 2009-05-20

Last Posted Date: 2009-09-23

Lead Sponsor: Teva Pharmaceuticals USA

Target Recruit Count: 18

Registration Number: NCT00904943

Locations: 🇨🇦
Anapharm Inc., Sainte-Foy, Quebec, Canada

Levetiracetam 1000 mg Under Non-Fasting Conditions

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Keppra®
Drug: Levetiracetam

First Posted Date: 2009-03-11

Last Posted Date: 2024-08-20

Lead Sponsor: Teva Pharmaceuticals USA

Target Recruit Count: 22

Registration Number: NCT00859430

Locations: 🇺🇸
CEDRA Clinical Research, LLC, San Antonio, Texas, United States

Levetiracetam 1000 mg Under Fasting Conditions

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Keppra®
Drug: Levetiracetam

First Posted Date: 2009-03-11

Last Posted Date: 2024-08-20

Lead Sponsor: Teva Pharmaceuticals USA

Target Recruit Count: 30

Registration Number: NCT00859521

Locations: 🇺🇸
CEDRA Clinical Research, LLC, San Antonio, Texas, United States

Levetiracetam 750 mg Tablets Under Non-Fasting Conditions

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Keppra®
Drug: Levetiracetam

First Posted Date: 2009-02-24

Last Posted Date: 2009-09-11

Lead Sponsor: Teva Pharmaceuticals USA

Target Recruit Count: 22

Registration Number: NCT00849485

Locations: 🇨🇦
SFBC Anapharm, Sainte-Foy, Quebec, Canada

Oxcarbazepine 600 mg Tablets Under Fasting Conditions

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Trileptal®
Drug: Oxcarbazepine

First Posted Date: 2009-02-24

Last Posted Date: 2024-08-19

Lead Sponsor: Teva Pharmaceuticals USA

Target Recruit Count: 60

Registration Number: NCT00850174

Locations: 🇨🇦
Pharma Medica Research Inc., Toronto, Ontario, Canada

Oxcarbazepine 600 mg Tablets Under Non-Fasting Conditions

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Trileptal®
Drug: Oxcarbazepine

First Posted Date: 2009-02-24

Last Posted Date: 2024-08-19

Lead Sponsor: Teva Pharmaceuticals USA

Target Recruit Count: 120

Registration Number: NCT00849797

Locations: 🇨🇦
SFBC Anapharm, Montreal, Quebec, Canada

Levetiracetam 750 mg Tablets Under Fasting Conditions

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Levetiracetam
Drug: Keppra®

First Posted Date: 2009-02-24

Last Posted Date: 2009-09-11

Lead Sponsor: Teva Pharmaceuticals USA

Target Recruit Count: 22

Registration Number: NCT00849862

Locations: 🇨🇦
SFBC-Anapharm, Sainte-Foy, Quebec, Canada

Sumatriptan Succinate 100 mg Tablets Under Non-Fasting Conditions

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Imitrex®
Drug: Sumatriptan Succinate

First Posted Date: 2009-02-19

Last Posted Date: 2009-09-11

Lead Sponsor: Teva Pharmaceuticals USA

Target Recruit Count: 28

Registration Number: NCT00846885

Locations: 🇺🇸
Gateway Medical Research, Inc., St. Charles, Missouri, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy